Overexpression of secretory phospholipase A2-IIa supports cancer stem cell phenotype via HER/ERBB-elicited signaling in lung and prostate cancer cells.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  International Journal of Oncology

• Publication date

  2017-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/ijo.2017.3964PMID 28440478
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cancer stem cells in drug resistant lung cancer: Targeting cell surface markers and signaling pathways.

  2016cited by this paper
• Lung cancer stem cells: The root of resistance.

  2016cited by this paper
• The metabolic state of cancer stem cells-a valid target for cancer therapy?

  2015cited by this paper
• The EGFR-HER2 module: a stem cell approach to understanding a prime target and driver of solid tumors

  2015cited by this paper
• Cancer stem cell phenotype is supported by secretory phospholipase A2 in human lung cancer cells.

  2014cited by this paper
• Contributions of epithelial-mesenchymal transition and cancer stem cells to the development of castration resistance of prostate cancer

  2014cited by this paper
• Cancer stem cells and cisplatin-resistant cells isolated from non-small-lung cancer cell lines constitute related cell populations

  2014cited by this paper
• Secretory phospholipase A2-IIa upregulates HER/HER2-elicited signaling in lung cancer cells

  2014cited by this paper
• Aldehyde dehydrogenase 1, a functional marker for identifying cancer stem cells in human nasopharyngeal carcinoma.

  2013cited by this paper
• Aldehyde dehydrogenases in cellular responses to oxidative/electrophilic stress.

  2013cited by this paper
• Targeting apoptosis pathways in cancer stem cells.

  2013cited by this paper
• The role of aldehyde dehydrogenase (ALDH) in cancer drug resistance.

  2013cited by this paper
• Prostate cancer stem‐like cells/cancer‐initiating cells have an autocrine system of hepatocyte growth factor

  2013cited by this paper
• Plasma Levels of Phospholipase A2-IIA in Patients with Different Types of Malignancies: Prognosis and Association with Inflammatory and Coagulation Biomarkers

  2013cited by this paper
• Differential Effects of Drugs Targeting Cancer Stem Cell (CSC) and Non-CSC Populations on Lung Primary Tumors and Metastasis

  2013cited by this paper
• Combined gemcitabine and CHK1 inhibitor treatment induces apoptosis resistance in cancer stem cell-like cells enriched with tumor spheroids from a non-small cell lung cancer cell line

  2013cited by this paper
• Ionizing Radiation Induces Stemness in Cancer Cells

  2012cited by this paper
• Gene expression profiles of prostate cancer stem cells isolated by aldehyde dehydrogenase activity assay.

  2012cited by this paper
• EGFR/Src/Akt signaling modulates Sox2 expression and self-renewal of stem-like side-population cells in non-small cell lung cancer

  2012cited by this paper
• The cancer stem-cell hypothesis: its emerging role in lung cancer biology and its relevance for future therapy.

  2012cited by this paper
• Radiation‐Induced Reprogramming of Breast Cancer Cells

  2012cited by this paper
• Knockdown of secretory phospholipase A2 IIa reduces lung cancer growth in vitro and in vivo.

  2012cited by this paper
• Secretory phospholipase A2‐IIa is a target gene of the HER/HER2‐elicited pathway and a potential plasma biomarker for poor prognosis of prostate cancer

  2012cited by this paper
• Aldehyde dehydrogenase activity selects for the holoclone phenotype in prostate cancer cells.

  2011cited by this paper
• Vav3 oncogene is involved in regulation of secretory phospholipase A2-IIa expression in prostate cancer.

  2011cited by this paper
• Plasma secretory phospholipase A2-IIa as a potential biomarker for lung cancer in patients with solitary pulmonary nodules

  2011cited by this paper
• Aldehyde dehydrogenase: Its role as a cancer stem cell marker comes down to the specific isoform

  2011cited by this paper
• Secretory phospholipase A2-IIa is involved in prostate cancer progression and may potentially serve as a biomarker for prostate cancer.

  2010cited by this paper
• Secreted PLA2 induces proliferation in astrocytoma through the EGF receptor: another inflammation-cancer link.

  2010cited by this paper
• Stem cell characteristics in prostate cancer cell lines.

  2010cited by this paper
• Emerging roles for phospholipase A2 enzymes in cancer.

  2010cited by this paper
• Establishment and characterization of multi-drug resistant, prostate carcinoma-initiating stem-like cells from human prostate cancer cell lines 22RV1

  2010cited by this paper
• Secreted phospholipase A2‐IIA modulates key regulators of proliferation on astrocytoma cells

  2009cited by this paper
• ALDH1A1 Is a Marker for Malignant Prostate Stem Cells and Predictor of Prostate Cancer Patients’ Outcome

  2009cited by this paper
• Ligand-independent androgen receptor variants derived from splicing of cryptic exons signify hormone-refractory prostate cancer.

  2009cited by this paper
• Group IIA phospholipase A2 as a prognostic marker in prostate cancer: relevance to clinicopathological variables and disease‐specific mortality

  2009cited by this paper
• Inflammatory protein sPLA(2)-IIA abrogates TNFalpha-induced apoptosis in human astroglioma cells: Crucial role of ERK.

  2009cited by this paper
• Aldehyde Dehydrogenase 1 Is a Tumor Stem Cell-Associated Marker in Lung Cancer

  2009cited by this paper
• Recent Progress on Tissue-Resident Adult Stem Cell Biology and Their Therapeutic Implications

  2008cited by this paper
• Cytosolic Phospholipase A2-α: A Potential Therapeutic Target for Prostate Cancer

  2008cited by this paper
• Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance.

  2008cited by this paper
• Pro-inflammatory Secretory Phospholipase A2 Type IIA Binds to Integrins αvβ3 and α4β1 and Induces Proliferation of Monocytic Cells in an Integrin-dependent Manner*

  2008cited by this paper
• Role of the MRP1/ABCC1 Multidrug Transporter Protein in Cancer

  2007cited by this paper
• Targeting HER proteins in cancer therapy and the role of the non-target HER3

  2007cited by this paper
• Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells.

  2007cited by this paper
• Recent advances in cancer stem/progenitor cell research: therapeutic implications for overcoming resistance to the most aggressive cancers

  2007cited by this paper
• Characterization of benign and malignant prostate epithelial Hoechst 33342 side populations

  2007cited by this paper
• Identification of genes potentially involved in the acquisition of androgen‐independent and metastatic tumor growth in an autochthonous genetically engineered mouse prostate cancer model

  2007cited by this paper
• Phospholipase A2 as targets for anti-cancer drugs.

  2007cited by this paper
• Expression of secretory phospholipase A2 in colon tumor cells potentiates tumor growth

  2007cited by this paper
• Modulation of multidrug resistance efflux pump activity to overcome chemoresistance in cancer.

  2006cited by this paper
• Secretory phospholipases A2 in inflammatory and allergic diseases: not just enzymes.

  2005cited by this paper
• Phosphotyrosine interactome of the ErbB-receptor kinase family

  2005cited by this paper
• Erlotinib in lung cancer - molecular and clinical predictors of outcome.

  2005cited by this paper
• Oncogenic Action of Secreted Phospholipase A2 in Prostate Cancer

  2004cited by this paper
• Decreased lung tumorigenesis in mice genetically deficient in cytosolic phospholipase A2.

  2004cited by this paper
• Akt as a Mediator of Secretory Phospholipase A2 Receptor-Involved Inducible Nitric Oxide Synthase Expression 1

  2003cited by this paper
• Secretory Phospholipases A2 Activate Selective Functions in Human Eosinophils1

  2003cited by this paper
• Transcriptional regulation of the rat type IIA phospholipase A2 gene by cAMP and interleukin-1beta in vascular smooth muscle cells: interplay of the CCAAT/enhancer binding protein (C/EBP), nuclear factor-kappaB and Ets transcription factors.

  2002cited by this paper
• Expression of epidermal growth factor receptor correlates with disease relapse and progression to androgen-independence in human prostate cancer.

  2002cited by this paper
• Expression of group IIA secretory phospholipase A2 is elevated in prostatic intraepithelial neoplasia and adenocarcinoma.

  2002cited by this paper
• Her-2/neu expression in prostate cancer: high level of expression associated with exposure to hormone therapy and androgen independent disease.

  2001cited by this paper
• HER-2/neu (p185neu) protein expression in the natural or treated history of prostate cancer.

  2001cited by this paper
• Expression of group IIa secretory phospholipase A2 increases with prostate tumor grade.

  2001cited by this paper
• Her-2-neu expression and progression toward androgen independence in human prostate cancer.

  2000cited by this paper
• Increasing molecular diversity of secreted phospholipases A(2) and their receptors and binding proteins.

  2000cited by this paper
• Receptors for a growing family of secreted phospholipases A2.

  1999cited by this paper
• A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase

  1999cited by this paper
• Both Group IB and Group IIA Secreted Phospholipases A2 Are Natural Ligands of the Mouse 180-kDa M-type Receptor*

  1999cited by this paper
• From HER2/Neu signal cascade to androgen receptor and its coactivators: a novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells.

  1999cited by this paper
• Molecular mechanisms of androgen-independent growth of human prostate cancer LNCaP-AI cells.

  1999cited by this paper
• Group II phospholipase A2 in human male reproductive organs and genital tumors

  1998cited by this paper
• Secretory Phospholipase A2 Activates the Cascade of Mitogen-activated Protein Kinases and Cytosolic Phospholipase A2 in the Human Astrocytoma Cell Line 1321N1*

  1998cited by this paper
• Induction of cyclooxygenase-2 by secretory phospholipases A2 in nerve growth factor-stimulated rat serosal mast cells is facilitated by interaction with fibroblasts and mediated by a mechanism independent of their enzymatic functions.

  1998cited by this paper
• Identification of the Binding Domain for Secretory Phospholipases A2 on Their M-type 180-kDa Membrane Receptor *

  1995cited by this paper
• Printed in U.S.A. Copyright © 1999 by The Endocrine Society Molecular Mechanisms of Androgen-Independent Growth of Human Prostate Cancer LNCaP-AI Cells*

  year unknowncited by this paper

• Translating preclinical insights into clinical strategies: Targeting cancer stem cells and stemness in prostate cancer.

  2025cites this paper
• Role of PLA2G2A rs11573156 C > G polymorphism in phospholipase expression and prostate cancer metastatic potential.

  2025cites this paper
• Molecular hydrophilicity dictates the membrane-disruptive efficacy of bile acid-modified lipids in secretory phospholipase A2-responsive liposomes

  2025cites this paper
• Targeting secreted PLA2 interactions with EGFR and vimentin to arrest prostate tumour growth

  2025cites this paper
• Stem Cell-Associated Proteins and Extracellular Matrix Composition of the Human Atrioventricular Junction

  2024cites this paper
• The impact of inflammation and acute phase activation in cancer cachexia

  2023cites this paper
• Phospholipase Family Enzymes in Lung Cancer: Looking for Novel Therapeutic Approaches

  2023cites this paper
• Secretory phospholipase (sPLA2-IIA) regulates breast cancer stem cells differentiation and metastatic potential.

  2023cites this paper
• 4-Amino-TEMPO loaded liposomes as sensitive EPR and OMRI probes for the detection of phospholipase A2 activity

  2023cites this paper
• Tumor Abnormality-Oriented Nanomedicine Design.

  2023cites this paper
• ERBB Signaling Pathway in Cancer Stem Cells.

  2022cites this paper
• Non-Targeted Serum Lipidomics Analysis and Potential Biomarkers of Laryngeal Cancer Based on UHPLC-QTOF-MS

  2022cites this paper
• Secretory phospholipase sPLA2-IIAloss impairs tumorigenic and metastatic potential in breast cancer cells.

  2022cites this paper
• Human Group IIA Phospholipase A2—Three Decades on from Its Discovery

  2021cites this paper
• Proliferating cell nuclear antigen directly interacts with androgen receptor and enhances androgen receptor‑mediated signaling.

  2021cites this paper
• Comparison of sPLA2IIA performance with high-sensitive CRP neutrophil percentage PCT and lactate to identify bacterial infection

  2021cites this paper
• Phospholipase A2 Drives Tumorigenesis and Cancer Aggressiveness through Its Interaction with Annexin A1

  2021cites this paper
• Interplay of Epidermal Growth Factor Receptor and Signal Transducer and Activator of Transcription 3 in Prostate Cancer: Beyond Androgen Receptor Transactivation

  2021cites this paper
• Emodin induces apoptosis and suppresses non-small-cell lung cancer growth via downregulation of sPLA2-IIa.

  2021cites this paper
• Association of 5'UTR polymorphism of secretory Phospholipase A2 group IIA (PLA2G2A) gene with Prostate Cancer Metastasis.

  2020cites this paper
• Sterically stabilized liposomes targeting P21 (RAC1) activated kinase-1 and secreted phospholipase A2 suppress prostate cancer growth and metastasis

  2020cites this paper
• Secretory Phospholipase A2 IIa Mediates Expression of Growth Factor Receptors in Esophageal Adenocarcinoma

  2020cites this paper
• Enzyme-Triggered Release of the Antisense Octaarginine-PNA Conjugate from Phospholipase A2 Sensitive Liposomes.

  2020cites this paper
• Long non-coding RNA SLNCR1 regulates non-small cell lung cancer migration, invasion and stemness through interactions with secretory phospholipase A2

  2019cites this paper
• Molecular Therapeutic Targets in Tobacco-Induced Lung Pathology

  2019cites this paper
• Context-dependent effect of sPLA2-IIA induced proliferation on murine hair follicle stem cells and human epithelial cancer

  2019cites this paper
• Impact of RNA‑binding motif 3 expression on the whole transcriptome of prostate cancer cells: An RNA sequencing study.

  2018cites this paper